XEN® Gel Stent compared to PRESERFLO™ MicroShunt implantation for primary open-angle glaucoma: two-year results.
Lotte M J ScheresStefani Kujovic-AleksovWishal D RamdasRonald M P C de CromLianne C G RoelofsTos T J M BerendschotCarroll A B WebersHenny J M BeckersPublished in: Acta ophthalmologica (2020)
Xen Gel Stent and PreserFlo MicroShunt implantations achieved comparable results in POAG eyes in terms of IOP-lowering and surgical success, with a similar high safety profile.